High purity 99% factory price in stock Dapagliflozin powder CAS NO.461432-26-8
- FOB Price: USD: 52.00-200.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
Medicine Grade(1-99)KilogramMedicine Grade(100-1000)Kilogram
- Product Details
Keywords
- Dapagliflozin
- factory price
- High purity 99%
Quick Details
- ProName: High purity 99% factory price in stock...
- CasNo: 461432-26-8
- Molecular Formula: C21h25clo6
- Appearance: White powder
- Application: Dapagliflozin A sodium-glucose transp...
- DeliveryTime: in 7 days afte your payment ( in stock...
- PackAge: 1kg/bag ;5kg/drum:25KG/drum
- Port: any port in China
- ProductionCapacity: 20 Metric Ton/Month
- Purity: 99% up
- Storage: in low tempreture
- Transportation: in low tempreture
- LimitNum: 1 Kilogram
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Why choose us
1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin
Details
Product Information
Product Name | Dapagliflozin |
CAS | 461432-26-8 |
MF | C21H25ClO6 |
MW | 408.87 |
Density | 1.349 |
Appearance | White Crystalline Powder |
Assay | 98%min |
Usage
Dapagliflozin is indicated for the management of diabetes mellitus type 2, and functions to improve glycemic control in adults when combined with diet and exercise. Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor, which prevents glucose reabsorption in the kidney. Using dapagliflozin leads to heavy glycosuria (glucose excretion in the urine), which can lead to weight loss and tiredness. Dapagliflozin was approved by the FDA on Jan 08, 2014. Dapagliflozin is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
COA
Product Name | Dapagliflozin | |
Reference | USDMF standard | |
Test Items | Specifications | Results |
Appearance | Off-white to yellowish powder | Off-white powder |
Identification | 1) Infrared absorption spectrum corresponds to the spectrum obtained with Dapagliflozin RS. | Conforms |
2) The retention time of the major peak of sample solution corresponds to that of the standard solution, as obtained in the assay. | Conforms | |
Water | 3.4%-4.3% | 3.6% |
Residue on ignition | ≤0.1% | <0.1% |
Related substances (HPLC) | Five-membered heterocyclic impurity≤0.15% | |
α-isomer≤0.15% | ||
Any unspecified impurity≤0.10% | ||
Total impurities≤1.0% | ||
Genotoxic impurity(LC/MS) | Methyl methanesulfonate≤60ppm | |
Assay (HPLC) | 98.0% -102.0% (Calculated on anhydrous and solvent-free basis) | 99.5% |
(S)-1,2-propanediol (GC) | 13.6%-16.6% | 13.8% |
Residual solvents (GC) | Dichloromethane≤600ppm | |
Ethyl acetate≤5000ppm | ||
Ethanol≤5000ppm | ||
Toluene≤890ppm | ||
Methanol≤3000ppm | ||
n-heptane≤5000ppm | ||
Tertrahydrofuran≤720ppm | ||
Cyclohexane≤3880ppm | 34ppm | |
Isopropyl acetate≤5000ppm | 104ppm | |
Conclusion | Complies with USDMF standard |